Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian Blagg

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Organic & Biomolecular Chemistry|February 23, 2013
Regioselective C2-arylation of imidazo[4,5-b]pyridinesJonathan Macdonald, Victoria Oldfield, Vassilios Bavetsias, et al.
Journal of Chemical Information and Modeling|June 10, 2015
MOARF, an Integrated Workflow for Multiobjective Optimization: Implementation, Synthesis, and Biological EvaluationNicholas C Firth, Butrus Atrash, Nathan Brown, et al.
Plos One|August 6, 2014
Diverse functionalization of Aurora-A kinase at specified surface and buried sites by native chemical modificationFiona Rowan, Meirion Richards, Marcella Widya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate CancerAdam Sharp, Jonathan Welti, Julian Blagg, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 13, 2009
Physicochemical drug properties associated with in vivo toxicological outcomes: a reviewDavid A Price, Julian Blagg, Lyn Jones, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
The tetrahydrobiopterin pathway and painAlasdair M Naylor, Kevin R Pojasek, Andrew L Hopkins, et al.
The Journal of Biological Chemistry|October 1, 2010
Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR)Jasmeen Oberoi, Mark W Richards, Simon Crumpler, et al.
Chemical Science|April 25, 2019
Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylationJames A H Gilburt, Paul Girvan, Julian Blagg, et al.
Pediatric Blood & Cancer|June 18, 2019
Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategyAntonio Romo-Morales, Ewa Aladowicz, Julian Blagg, et al.
ACS Chemical Biology|August 9, 2013
Insights into Aurora-A kinase activation using unnatural amino acids incorporated by chemical modificationFiona C Rowan, Meirion Richards, Rachel A Bibby, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Organic & Biomolecular Chemistry|February 23, 2013
Regioselective C2-arylation of imidazo[4,5-b]pyridinesJonathan Macdonald, Victoria Oldfield, Vassilios Bavetsias, et al.
Journal of Chemical Information and Modeling|June 10, 2015
MOARF, an Integrated Workflow for Multiobjective Optimization: Implementation, Synthesis, and Biological EvaluationNicholas C Firth, Butrus Atrash, Nathan Brown, et al.
Plos One|August 6, 2014
Diverse functionalization of Aurora-A kinase at specified surface and buried sites by native chemical modificationFiona Rowan, Meirion Richards, Marcella Widya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2016
Targeting Androgen Receptor Aberrations in Castration-Resistant Prostate CancerAdam Sharp, Jonathan Welti, Julian Blagg, et al.
Expert Opinion on Drug Metabolism & Toxicology|June 13, 2009
Physicochemical drug properties associated with in vivo toxicological outcomes: a reviewDavid A Price, Julian Blagg, Lyn Jones, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|January 5, 2010
The tetrahydrobiopterin pathway and painAlasdair M Naylor, Kevin R Pojasek, Andrew L Hopkins, et al.
The Journal of Biological Chemistry|October 1, 2010
Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR)Jasmeen Oberoi, Mark W Richards, Simon Crumpler, et al.
Chemical Science|April 25, 2019
Ligand discrimination between active and inactive activation loop conformations of Aurora-A kinase is unmodified by phosphorylationJames A H Gilburt, Paul Girvan, Julian Blagg, et al.
Pediatric Blood & Cancer|June 18, 2019
Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategyAntonio Romo-Morales, Ewa Aladowicz, Julian Blagg, et al.
ACS Chemical Biology|August 9, 2013
Insights into Aurora-A kinase activation using unnatural amino acids incorporated by chemical modificationFiona C Rowan, Meirion Richards, Rachel A Bibby, et al.
Pageof 9